LANGEPHARM ApS: Financial statements 2019
CVR: 25198956
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
LANGEPHARM ApS (CVR 25198956) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 184,031 and a net result of DKK 161,588 compared with DKK 89,481 the year before. That is a decrease of 10.4% compared with the year before. Equity in the 2019 report amounted to DKK 1,102,993. The solvency ratio was 87.8%.
- Gross Profit
- DKK 184,031
- Profit/Loss
- DKK 161,588
- Equity
- DKK 1,102,993
- Total Assets
- DKK 1,256,652
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 184 t. | 162 t. | 1.1 mio. | 0 |
| 2018 | - | 205 t. | 89 t. | 941 t. | 1 |
| 2017 | - | 197 t. | 104 t. | 852 t. | 1 |
| 2016 | - | 129 t. | 115 t. | 748 t. | - |
| 2015 | - | 102 t. | 77 t. | 633 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
LANGEPHARM ApS has published its annual report for 2018. Gross profit came to DKK 205,310, and the net result was DKK 89,481.
About LANGEPHARM ApS
LANGEPHARM ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company has been dissolved on 29 March 2023. The company was registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named SKIN CARE CONSULTING ApS. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -8,468 and a net result of DKK -6,610 compared with DKK -9,353 the year before. Equity in the 2022 report amounted to DKK 823,059.